Immunohistochemical Detection of EWS and FLI-1 Proteins in Ewing Sarcoma and Primitive Neuroectodermal Tumors: Comparative Analysis With CD99 (MIC-2) Expression
Authors:
- Antonio Llombart-BoschAntonio Llombart-Bosch
- Samuel NavarroSNSamuel Navarro
- 1 September 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 9 (3) , 255-260
Abstract
The molecular analysis of the t(11;22) rearrangement involving EWS/FLI-1 genes is likely to be of diagnostic value in Ewing sarcoma (ES) and primitive neuroectodermal tumors (PNET). The objective of the current study was to analyze the immunohistochemical expression of the EWS and FLI-1 proteins in a group of small round-cell tumors (SRCT) to determine their specificity and relevance in their differential diagnosis. Forty-eight cases-10 conventional ES, 4 large-cell ES, 5 PNET, 9 neuroblastomas (NB), 6 undifferentiated synovial sarcomas (SS), 5 rhabdomyosarcomas (RB), 5 non-Hodgkin lymphomas (NHL), 1 round-cell liposarcoma, and 3 mesenchymal chondrosarcomas-were analyzed. Immunocytochemistry was performed on paraffin sections after the LSAB method and antigen retrieval using ethylenediaminetetraacetic acid buffer (pH 6). Primary antibodies included FLI-1 (C-19), EWS (N-18), EWS (C-19), and CD99 (MIC-2). As expected, CD-99 expression was found in 100% of ES/PNET cases, in 2 cases of RB, 2 SS, and 1 NHL. FLI-1 protein was observed as nuclear staining in 16 cases of ES/PNET (84%) and in 4 cases of NHL, 2 NB, and 3 SS. Normal endothelial cells and lymphocytes also were positive. EWS expression (both proteins N-18 and C-19) was detected not only in 95% of ES/PNET cases but also in more than 50% of cases from the other tumoral types (4 of 9 and 7 of 9 NB, 5 of 6 and 6 of 6 SS, 3 of 5 and 5 of 5 RB, and 2 of 5 and 3 of 5 NHL, respectively). Whereas EWS expression does not appear specific for ES/PNET, analysis of FLI-1 expression together with CD-99 is a powerful marker for ES/PNET and important factors in the differential diagnosis of SRCT.Keywords
This publication has 22 references indexed in Scilit:
- Detection of EWS/FLI‐1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing′s Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin‐Embedded Archival MaterialSarcoma, 1999
- EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.Journal of Clinical Oncology, 1998
- Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blottingVirchows Archiv, 1998
- Production and Characterization of Mouse Monoclonal Antibodies to Wild-Type and Oncogenic FLI-1 ProteinsHybridoma, 1997
- Detection of t(11;22)(q24;ql2) Translocation Breakpoint in Paraffin-embedded Tissue of the Ewingʼs Sarcoma Family by Nested Reverse Transcription-Polymerase Chain ReactionDiagnostic Molecular Pathology, 1996
- The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric TranscriptsNew England Journal of Medicine, 1994
- Immunohistochemical Profile of Monoclonal Antibody 013American Journal of Surgical Pathology, 1994
- Ewing's sarcoma—Routine diagnostic utilization of MIC2 analysis: A pediatric oncology group/children's cancer group intergroup studyHuman Pathology, 1994
- Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpointsGenes, Chromosomes and Cancer, 1992
- Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12)Cancer Genetics and Cytogenetics, 1988